Taproot Management’s Labcorp LH Stock Holding History

Taproot Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,425	Closed	-$3.05M	–	93
2026 Q1	$3.05M	Buy	+11,425	New	+$3.09M	0.58%	73

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Taproot Management's LH Position: Q2 2026 in Review

Taproot Management sold out of Labcorp (LH) in Q2 2026, closing a stake of 11,425 shares — an estimated $3.05M sold.

Taproot Management first reported a position in LH in Q1 2026 and held it in 1 quarter. The position peaked at $3.05M in Q1 2026. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

Taproot Management reported no remaining Labcorp position as of Q2 2026 after selling out during the quarter.
Taproot Management sold 11,425 Labcorp shares in Q2 2026, an estimated $3.05M.
Taproot Management first reported a position in Labcorp in Q1 2026 and held it in 1 quarter.
Taproot Management's Labcorp position peaked at $3.05M in Q1 2026.
1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Taproot Management's 13F filing for Q2 2026.